세계의 바이오소재 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2032년)

The global demand for Biomaterials Market is presumed to reach the market size of nearly USD 814.4 Billion by 2032 from USD 210.53 Billion in 2023 with a CAGR of 16.22% under the study period 2024-2032.

Biomaterials are natural or synthetic substances created to interact with biological systems for medical purposes. They are used in various applications, including implants, prosthetics, tissue engineering, and drug delivery systems. These materials can be categorized into several types: metals, ceramics, polymers, and composites, each with specific properties suited for different medical applications. For example, biocompatible polymers may be used in drug delivery systems attributed to their ability to dissolve and release medication over time, while metals and ceramics are often used in orthopedic implants due to their strength and durability.

Market Dynamics

The biomaterials market is propelled by the increasing prevalence of chronic diseases and age-related conditions, heightening the demand for advanced medical implants and prosthetics. Biomaterials are essential in developing innovative treatments for cardiovascular diseases, bone disorders, and tissue damage. Additionally, the rise of personalized medicine is creating opportunities for bio-materials tailored to individual patient needs, enhancing the effectiveness of treatments. Technological advancements drive market growth, particularly tissue engineering and regenerative medicine innovations. For example, the development of 3D printing technologies for creating customized biomaterial implants is revolutionizing the field, offering precision and improved patient outcomes.

Furthermore, increased research and investment in biodegradable and eco-friendly biomaterials align with growing environmental and sustainability concerns, presenting new avenues for market expansion. Strategic partnerships between medical device companies, research institutions, and universities facilitate the development of cutting-edge biomaterials and accelerate their commercialization. The expanding applications of bio-materials in drug delivery systems, wound care, and diagnostic devices also contribute to market growth, reflecting the versatility and potential of these materials in advancing medical technology. However, high production costs and regulatory challenges can restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Biomaterials. The growth and trends of Biomaterials industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Biomaterials market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Metallic
• Natural
• Ceramics
• Polymers

By Application

• Cardiovascular
• Ophthalmology
• Dental
• Orthopedic
• Wound Healing
• Tissue Engineering
• Neurology
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biomaterials market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biomaterials market include Medtronic, Evonik Industries AG, Carpenter Technology Corporation, Berkeley Advanced Biomaterials, Invibio Ltd., Zimmer Biomet Holdings Inc., BASF SE, Covalon Technologies Ltd., Stryker, Johnson & Johnson, Dentsply Sirona, CoorsTek Inc., Corbion, Regenity Biosciences. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BIOMATERIALS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOMATERIALS MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Metallic Historic and Forecast Sales By Regions
• 5.4. Natural Historic and Forecast Sales By Regions
• 5.5. Ceramics Historic and Forecast Sales By Regions
• 5.6. Polymers Historic and Forecast Sales By Regions

6. GLOBAL BIOMATERIALS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Cardiovascular Historic and Forecast Sales By Regions
• 6.4. Ophthalmology Historic and Forecast Sales By Regions
• 6.5. Dental Historic and Forecast Sales By Regions
• 6.6. Orthopedic Historic and Forecast Sales By Regions
• 6.7. Wound Healing Historic and Forecast Sales By Regions
• 6.8. Tissue Engineering Historic and Forecast Sales By Regions
• 6.9. Neurology Historic and Forecast Sales By Regions
• 6.10. Others Historic and Forecast Sales By Regions

7. GLOBAL BIOMATERIALS MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE BIOMATERIALS COMPANIES

• 8.1. Biomaterials Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF BIOMATERIALS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Medtronic
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. Evonik Industries AG
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. Carpenter Technology Corporation
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. Berkeley Advanced Biomaterials
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. Invibio Ltd.
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. Zimmer Biomet Holdings Inc.
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. BASF SE
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. Covalon Technologies Ltd.
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. Stryker
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. Johnson & Johnson
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments
• 9.13. Dentsply Sirona
  • 9.13.1 Company Overview
  • 9.13.2 Company Revenue
  • 9.13.3 Products
  • 9.13.4 Recent Developments
• 9.14. CoorsTek Inc.
  • 9.14.1 Company Overview
  • 9.14.2 Company Revenue
  • 9.14.3 Products
  • 9.14.4 Recent Developments
• 9.15. Corbion
  • 9.15.1 Company Overview
  • 9.15.2 Company Revenue
  • 9.15.3 Products
  • 9.15.4 Recent Developments
• 9.16. Regenity Biosciences
  • 9.16.1 Company Overview
  • 9.16.2 Company Revenue
  • 9.16.3 Products
  • 9.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies